MENU

Fox Chase Cancer Center News

Breast cancer ribbon
October 9, 2020

Fox Chase Cancer Center Encourages Women to Schedule a Breast Cancer Screening

PHILADELPHIA (October 9, 2020)—October is Breast Cancer Awareness Month, and Fox Chase Cancer Center encourages women to schedule a screening mammogram for breast cancer. Screening mammograms can help detect breast cancer early, before any symptoms appear, and when there is better chance for successful treatment.

October 7, 2020

Fox Chase Researcher Receives 2020 NIH Director’s New Innovator Award

PHILADELPHIA (October 7, 2020)— Joan Font-Burgada, PhD, assistant professor in the Cancer Biology Research Program at Fox Chase Cancer Center, has received a National Institutes of Health (NIH) Director’s New Innovator Award from the NIH Common Fund’s High-Risk, High-Reward Research program.

October 6, 2020

Fox Chase Cancer Center Receives Press Ganey’s 2020 Guardian of Excellence Award

PHILADELPHIA (October 6, 2020)—Press Ganey has recognized Fox Chase Cancer Center with its 2020 Guardian of Excellence Award for providing outstanding clinical performance for patients in its outpatient clinics.

October 6, 2020

New Role Identified for KDMA as ‘Critical Regulator’ of Histone Gene Expression

PHILADELPHIA (October 6, 2020) – Researchers at Fox Chase Cancer Center have discovered a new function for the histone lysine demethylase KDM4A that supports its role as a “critical regulator” for replicative histones during the S phase of the cell cycle.

October 6, 2020

Fox Chase Researchers Link Lower Income and Levels of Health Literacy to Problems Coping After Treatment for Prostate Cancer

PHILADELPHIA (October 6, 2020)—In a recent study, researchers at Fox Chase Cancer Center found individuals with lower health literacy or income reported more practical issues and problems with coping following localized prostate cancer treatment.

October 1, 2020

Rates of Confirmatory Prostate Biopsy ‘Surprisingly Low’ With Use of Active Surveillance

PHILADELPHIA (October 1, 2020) – Active surveillance is being increasingly used as a treatment option for men diagnosed with low-risk prostate cancer. A recent study led by researchers at Fox Chase Cancer Center, however, has found that only about 60% of men who choose active surveillance are undergoing guideline-recommended confirmatory biopsy within 12 months of their diagnosis.

September 30, 2020

Fox Chase Cancer Center Receives Competitive SPORE Grant for Head and Neck Cancer Research Collaboration

PHILADELPHIA (September 30, 2020)—Researchers at Fox Chase Cancer Center were recently awarded a grant through the National Institute of Dental and Craniofacial Research to fund a Specialized Program of Research Excellence (SPORE) for Head and Neck Cancer.

September 28, 2020

Fox Chase Researchers Examine Benefits of Breast Imaging With Advanced Digital Technique

PHILADELPHIA (October 1, 2020)—Researchers at Fox Chase Cancer Center recently published a commentary examining clinical practices for breast cancer detection using traditional mammography versus digital breast tomosynthesis on baseline and subsequent screenings.

Pages

Connect with Fox Chase